抗甲状腺药

目标：本研究旨在比较患者给予不同治疗手段-碘化疗或抗甲状腺药后，TAO的发生和恶化情况。

Objectives : The aim of the study was to compare the occurrence of worsening or development of TAO in patients who were treated with radioiodine or antithyroid drugs .

肾上腺素能阻滞剂和兴奋剂及抗甲状腺药对鼠肝T4-5′-脱碘酶活性的影响

Adrenergic antagonist and agonist and antithyroid drugs on the activity of hepatic t_4-5 ' - deiodinase in rats

结合发病前有服用抗甲状腺药（PTU、MMI）5年以上病史，诊断为抗甲状腺药致RPGN。

They both had been diagnosed RPGN induced by antithyroid agents for 5 years because of Graves disease .

目的探讨服用抗甲状腺药[丙硫氧嘧啶（PTU）、甲巯咪唑（MMI）]致急进性肾小球肾炎（RPGN）的临床特征。

Objective To explore the clinical characteristic of rapidly progressive glomerulonephritis ( RPGN ) induced by the antithyroid agents [ propylthiouracil ( PTU ) and methimazole ( MMI ) ] .

结论：穴位封闭配合口服升白药治疗抗甲状腺药所致白细胞减少症，疗效明显高于单纯口服升白药者，与应用GCSF疗效相近。

Conclusions : The curative effects of point block combined with medicine of raising leukocyte taken orally on leukopenia induced by antithyroid preparation are significantly higher than those treated with medicine of raising leukocyte alone but similar to those treated with GCSF .

在综合护肝治疗同时加用小至中等剂量抗甲状腺药治疗后，82.5%病例肝功能恢复、甲亢症状控制。

Treated with general liver protective drug in combination with low to moderate dose of anti-Thyroid agent , 33 cases ( 82 . 5 % ) recovered .

西药占48.6%（53/109），居前三位的依次为解热镇痛消炎药、抗结核药、抗甲状腺药。

The western medicine accounted for 48.6 % ( 53 / 109 ), among which the most chief drugs were anti-inflammatory , antipyretic , antituberculotic and antithyroid drugs .